Ocelot Bio, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
Phase 2
Completed
- Conditions
- AscitesAcute Kidney InjuryCirrhosisHepatorenal Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Ocelot Bio, Inc
- Target Recruit Count
- 47
- Registration Number
- NCT05309200
- Locations
- 🇺🇸
Mayo Clinic - Phoenix, Phoenix, Arizona, United States
🇺🇸Keck Medical Center of USC, Los Angeles, California, United States
🇺🇸University of California, San Francisco Liver Clinic, San Francisco, California, United States
News
No news found